Non-tolerability of double-filtration plasmapheresis in antibody-incompatible kidney transplant candidates. 2015

Hadia Hebibi, and Hugo Weclawiak, and Lionel Rostaing, and Séverine Beaudreuil, and Asma Allal, and Hélène François, and Antoine Durrbach, and Nassim Kamar

Few studies have reported the use of double-filtration plasmapheresis (DFPP) in antibody-incompatible kidney transplantation. To assess the efficiency and tolerability of DFPP, we prospectively studied four chronic hemodialysis patients from two centers undergoing antibody-incompatible kidney transplantation. DFPP was used for ABO-incompatible transplantation (n = 1), for high human leukocyte antigen (HLA) immunization levels (n = 2) or for the presence of a donor-specific antibody (DSA) against a potential living donor (n = 1). In all the patients, the DFPP program was discontinued because of the adverse effects. Low blood pressure occurred during the first hour of the session in all the patients. A significant loss of plasma proteins, clotting factors and immunoglobulins also occurred during this treatment. In addition, fistula thrombosis was diagnosed in two patients. Three patients experienced gastrointestinal symptoms. The DFPP reduced the titers of the anti-B antibodies and reduced the levels of DSA in one patient, but had no effect on anti-HLA antibodies in the remaining two patients. Our study highlights the non-tolerability and poor efficacy of DFPP prior to antibody-incompatible kidney transplantation that limit its extensive use in the desensitization protocols.

UI MeSH Term Description Entries
D007518 Isoantibodies Antibodies from an individual that react with ISOANTIGENS of another individual of the same species. Alloantibodies
D008297 Male Males
D010956 Plasmapheresis Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. Double Filtration Plasmapheresis,Therapeutic Immunoadsorption,Therapeutic Plasma Adsorption,Therapeutic Plasmapheresis,Adsorption, Therapeutic Plasma,Adsorptions, Therapeutic Plasma,Double Filtration Plasmaphereses,Filtration Plasmapheresis, Double,Immunoadsorption, Therapeutic,Plasma Adsorption, Therapeutic,Plasmaphereses,Plasmapheresis, Double Filtration,Plasmapheresis, Therapeutic,Therapeutic Immunoadsorptions,Therapeutic Plasma Adsorptions,Therapeutic Plasmaphereses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001787 Blood Group Incompatibility An antigenic mismatch between donor and recipient blood. Antibodies present in the recipient's serum may be directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984). ABO Compatibility,ABO Incompatibility,Blood Group ABO Incompatibility,Blood Type Incompatibility,Rh Compatibility,Rh Incompatibility,ABO Compatibilities,ABO Incompatibilities,Blood Group Incompatibilities,Blood Type Incompatibilities,Compatibility, ABO,Compatibility, Rh,Incompatibilities, Blood Group,Incompatibility, ABO,Incompatibility, Blood Group,Incompatibility, Blood Type,Incompatibility, Rh,Rh Compatibilities,Rh Incompatibilities
D005602 France A country in western Europe bordered by the Atlantic Ocean, the English Channel, the Mediterranean Sea, and the countries of Belgium, Germany, Italy, Spain, Switzerland, the principalities of Andorra and Monaco, and by the duchy of Luxembourg. Its capital is Paris. Corsica,Saint Pierre and Miquelon,Miquelon and Saint Pierre,Miquelon and St. Pierre,St. Pierre and Miquelon
D006648 Histocompatibility The degree of antigenic similarity between the tissues of different individuals, which determines the acceptance or rejection of allografts. HLA Incompatibility,Histoincompatibility,Human Leukocyte Antigen Incompatibility,Immunocompatibility,Tissue Compatibility,Compatibility, Tissue,HLA Incompatibilities,Histocompatibilities,Histoincompatibilities,Immunocompatibilities,Incompatibility, HLA,Tissue Compatibilities
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000017 ABO Blood-Group System The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. ABH Blood Group,ABO Blood Group,ABO Factors,Blood Group H Type 1 Antigen,H Blood Group,H Blood Group System,ABO Blood Group System,Blood Group, ABH,Blood Group, ABO,Blood Group, H,Blood-Group System, ABO,Factors, ABO,System, ABO Blood-Group

Related Publications

Hadia Hebibi, and Hugo Weclawiak, and Lionel Rostaing, and Séverine Beaudreuil, and Asma Allal, and Hélène François, and Antoine Durrbach, and Nassim Kamar
August 2010, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,
Hadia Hebibi, and Hugo Weclawiak, and Lionel Rostaing, and Séverine Beaudreuil, and Asma Allal, and Hélène François, and Antoine Durrbach, and Nassim Kamar
December 2018, Transplantation proceedings,
Hadia Hebibi, and Hugo Weclawiak, and Lionel Rostaing, and Séverine Beaudreuil, and Asma Allal, and Hélène François, and Antoine Durrbach, and Nassim Kamar
October 2014, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation,
Hadia Hebibi, and Hugo Weclawiak, and Lionel Rostaing, and Séverine Beaudreuil, and Asma Allal, and Hélène François, and Antoine Durrbach, and Nassim Kamar
April 1998, Clinical transplantation,
Hadia Hebibi, and Hugo Weclawiak, and Lionel Rostaing, and Séverine Beaudreuil, and Asma Allal, and Hélène François, and Antoine Durrbach, and Nassim Kamar
April 2023, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
Hadia Hebibi, and Hugo Weclawiak, and Lionel Rostaing, and Séverine Beaudreuil, and Asma Allal, and Hélène François, and Antoine Durrbach, and Nassim Kamar
April 2015, Journal of the Formosan Medical Association = Taiwan yi zhi,
Hadia Hebibi, and Hugo Weclawiak, and Lionel Rostaing, and Séverine Beaudreuil, and Asma Allal, and Hélène François, and Antoine Durrbach, and Nassim Kamar
January 2003, Gynecologic and obstetric investigation,
Hadia Hebibi, and Hugo Weclawiak, and Lionel Rostaing, and Séverine Beaudreuil, and Asma Allal, and Hélène François, and Antoine Durrbach, and Nassim Kamar
February 2003, Transplantation proceedings,
Hadia Hebibi, and Hugo Weclawiak, and Lionel Rostaing, and Séverine Beaudreuil, and Asma Allal, and Hélène François, and Antoine Durrbach, and Nassim Kamar
November 2005, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA,
Hadia Hebibi, and Hugo Weclawiak, and Lionel Rostaing, and Séverine Beaudreuil, and Asma Allal, and Hélène François, and Antoine Durrbach, and Nassim Kamar
December 2007, Transplantation,
Copied contents to your clipboard!